Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Defining the optimal degree of heparin anticoagulation for peripheral vascular interventions: insight from a large, regional, multicenter registry.
Kasapis C, Gurm HS, Chetcuti SJ, Munir K, Luciano A, Smith D, Aronow HD, Kassab EH, Knox MF, Moscucci M, Share D, Grossman PM. Kasapis C, et al. Among authors: gurm hs. Circ Cardiovasc Interv. 2010 Dec;3(6):593-601. doi: 10.1161/CIRCINTERVENTIONS.110.957381. Epub 2010 Nov 9. Circ Cardiovasc Interv. 2010. PMID: 21062999
Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
Gurm HS, Smith DE, Chetcuti SJ, Share D, Khanal S, Riba A, Carter AJ, Lalonde T, Kline-Rogers E, O'Donnell M, O'Neill W, Safian R, Moscucci M; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Gurm HS, et al. J Interv Cardiol. 2007 Jun;20(3):197-203. doi: 10.1111/j.1540-8183.2007.00262.x. J Interv Cardiol. 2007. PMID: 17524111 Free article. Clinical Trial.
The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary intervention.
Gurm HS, Smith DE, Collins JS, Share D, Riba A, Carter AJ, LaLonde T, Kline-Rogers E, O'Donnell M, Changezi H, Zughaib M, Safian R, Moscucci M; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Gurm HS, et al. J Am Coll Cardiol. 2008 Feb 5;51(5):529-35. doi: 10.1016/j.jacc.2007.09.053. J Am Coll Cardiol. 2008. PMID: 18237680 Free article.
Relation between previous lipid-lowering therapy and infarct size (creatine kinase-MB level) in patients presenting with acute myocardial infarction.
Aronow HD, Lincoff AM, Quinn MJ, McRae AT, Gurm HS, Houghtaling PL, Granger CB, Harrington RA, Van de Werf F, Topol EJ, Lauer MS; GUSTO IIb and PURSUIT Trial Investigators. Aronow HD, et al. Among authors: gurm hs. Am J Cardiol. 2008 Nov 1;102(9):1119-24. doi: 10.1016/j.amjcard.2008.06.032. Epub 2008 Aug 27. Am J Cardiol. 2008. PMID: 18940276 Clinical Trial.
306 results